Delivery Order SPE2DB25D3003-SPE2DB25FPWXP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Armodafinil 250 mg tablets in 30-count units. This firm fixed-price delivery order, valued at $1,984.17, represents a non-competitive set-aside award and is scheduled for completion by August 20, 2025. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $2,199.45 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,779.24 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location in Conshohocken,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Armodafinil 250mg (30-count packages) with a ceiling value of $1,696.10. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for ultimate completion on July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $5,557.23 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Armodafinil 250 mg tablets in quantities of 30. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order is issued as a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,115.00 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count packages) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed price, non-set-aside contract will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,789.78 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) on July 29, 2025, with a completion date of July 30, 2025. This firm fixed price delivery order represents a non-set-aside, competitively awarded contract with performance at the vendor's Conshohocken, Pennsylvania facility. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,672.50 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count supply) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count packages) under a firm fixed-price contract valued at $3,655.82, with completion scheduled for July 29, 2025. This non-set-aside competitive award was issued on July 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Armodafinil is a wakefulness-promoting agent commonly used to treat narcolepsy, obstructive...
- The Defense Logistics Agency Troop Support Medical awarded a $78,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 150 mg armodafinil tablets. As the prime contractor, Amerisourcebergen will deliver 30 tablets to a facility in Conshohocken, Pennsylvania by August 30, 2023 in fulfillment of the agency's requirements. No additional details were provided regarding the original solicitation or any overarching contracts under which this delivery order was issued....
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB25FPWXPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Armodafinil 250 mg tablets in quantities of 30 units, with a ceiling value of $1,196.97. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 8, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contracts covering a comprehensive range of pharmaceutical products and medical supplies. As a prime vendor under the DLA's Pharmaceutical Prime Vendor program, AmerisourceBergen fulfills federal medical supply requirements across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard. This particular delivery order for Armodafinil, a wakefulness-promoting agent commonly used in military medicine, reflects the company's continued role in supplying specialized pharmaceutical commodities to support defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/7/25 |